Almost Family Inc. (NASDAQ: AFAM) Stock Competitors & Peer Comparison

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, HCA has a market cap of 91.3B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while HCA trades at $419.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas HCA's P/E ratio is 14.57. In terms of profitability, AFAM's ROE is +0.06%, compared to HCA's ROE of -1.13%. Regarding short-term risk, AFAM is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check HCA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, THC has a market cap of 21.7B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while THC trades at $264.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas THC's P/E ratio is 15.61. In terms of profitability, AFAM's ROE is +0.06%, compared to THC's ROE of +0.51%. Regarding short-term risk, AFAM is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check THC's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, EHC has a market cap of 12.1B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while EHC trades at $120.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas EHC's P/E ratio is 20.82. In terms of profitability, AFAM's ROE is +0.06%, compared to EHC's ROE of +0.25%. Regarding short-term risk, AFAM is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check EHC's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, FMS has a market cap of 12B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while FMS trades at $22.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas FMS's P/E ratio is 8.39. In terms of profitability, AFAM's ROE is +0.06%, compared to FMS's ROE of +0.07%. Regarding short-term risk, AFAM is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check FMS's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, DVA has a market cap of 11.7B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while DVA trades at $182.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas DVA's P/E ratio is 14.30. In terms of profitability, AFAM's ROE is +0.06%, compared to DVA's ROE of -1.24%. Regarding short-term risk, AFAM is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check DVA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, UHS has a market cap of 10.6B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while UHS trades at $171.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas UHS's P/E ratio is 7.80. In terms of profitability, AFAM's ROE is +0.06%, compared to UHS's ROE of +0.21%. Regarding short-term risk, AFAM is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check UHS's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, ENSG has a market cap of 10B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while ENSG trades at $172.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas ENSG's P/E ratio is 24.89. In terms of profitability, AFAM's ROE is +0.06%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, AFAM is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check ENSG's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while OSH trades at $39.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas OSH's P/E ratio is -17.65. In terms of profitability, AFAM's ROE is +0.06%, compared to OSH's ROE of +4.64%. Regarding short-term risk, AFAM is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check OSH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, PACS has a market cap of 7.1B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while PACS trades at $44.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas PACS's P/E ratio is 23.59. In terms of profitability, AFAM's ROE is +0.06%, compared to PACS's ROE of +0.27%. Regarding short-term risk, AFAM is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check PACS's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while CHE trades at $510.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas CHE's P/E ratio is 24.00. In terms of profitability, AFAM's ROE is +0.06%, compared to CHE's ROE of +0.29%. Regarding short-term risk, AFAM is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check CHE's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, HIMS has a market cap of 6.2B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while HIMS trades at $27.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas HIMS's P/E ratio is -43.62. In terms of profitability, AFAM's ROE is +0.06%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, AFAM is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check HIMS's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while LHCG trades at $169.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas LHCG's P/E ratio is 82.83. In terms of profitability, AFAM's ROE is +0.06%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, AFAM is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check LHCG's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, LFST has a market cap of 4.9B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while LFST trades at $13.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas LFST's P/E ratio is 95.05. In terms of profitability, AFAM's ROE is +0.06%, compared to LFST's ROE of +0.03%. Regarding short-term risk, AFAM is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check LFST's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, CON has a market cap of 4.4B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while CON trades at $34.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas CON's P/E ratio is 21.50. In terms of profitability, AFAM's ROE is +0.06%, compared to CON's ROE of +0.47%. Regarding short-term risk, AFAM is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check CON's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while NHC trades at $224.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas NHC's P/E ratio is 29.09. In terms of profitability, AFAM's ROE is +0.06%, compared to NHC's ROE of +0.13%. Regarding short-term risk, AFAM is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check NHC's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, OPCH has a market cap of 3.5B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while OPCH trades at $23.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas OPCH's P/E ratio is 13.74. In terms of profitability, AFAM's ROE is +0.06%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, AFAM is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check OPCH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AMED trades at $100.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AMED's P/E ratio is 39.30. In terms of profitability, AFAM's ROE is +0.06%, compared to AMED's ROE of +0.11%. Regarding short-term risk, AFAM is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check AMED's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AVAH has a market cap of 3.1B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AVAH trades at $13.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AVAH's P/E ratio is 20.62. In terms of profitability, AFAM's ROE is +0.06%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, AFAM is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check AVAH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, BKD has a market cap of 2.9B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while BKD trades at $12.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas BKD's P/E ratio is -20.94. In terms of profitability, AFAM's ROE is +0.06%, compared to BKD's ROE of +4.06%. Regarding short-term risk, AFAM is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check BKD's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, GRDN has a market cap of 2.7B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while GRDN trades at $42.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas GRDN's P/E ratio is 38.03. In terms of profitability, AFAM's ROE is +0.06%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, AFAM is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check GRDN's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while ACHC trades at $28.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas ACHC's P/E ratio is 14.17. In terms of profitability, AFAM's ROE is +0.06%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, AFAM is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check ACHC's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while ADUS trades at $117.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas ADUS's P/E ratio is 17.85. In terms of profitability, AFAM's ROE is +0.06%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, AFAM is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check ADUS's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while MD trades at $27.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas MD's P/E ratio is 12.09. In terms of profitability, AFAM's ROE is +0.06%, compared to MD's ROE of +0.20%. Regarding short-term risk, AFAM is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check MD's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, SEM has a market cap of 2B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while SEM trades at $16.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas SEM's P/E ratio is 15.43. In terms of profitability, AFAM's ROE is +0.06%, compared to SEM's ROE of +0.08%. Regarding short-term risk, AFAM is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check SEM's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, ASTH has a market cap of 1.9B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while ASTH trades at $38.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas ASTH's P/E ratio is 45.86. In terms of profitability, AFAM's ROE is +0.06%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, AFAM is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check ASTH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while SNDA trades at $39.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas SNDA's P/E ratio is -6.39. In terms of profitability, AFAM's ROE is +0.06%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, AFAM is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check SNDA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, SGRY has a market cap of 1.8B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while SGRY trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas SGRY's P/E ratio is 36.21. In terms of profitability, AFAM's ROE is +0.06%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, AFAM is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check SGRY's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AMEH trades at $40.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AMEH's P/E ratio is 39.25. In terms of profitability, AFAM's ROE is +0.06%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, AFAM is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check AMEH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while ARDT trades at $10.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas ARDT's P/E ratio is 8.98. In terms of profitability, AFAM's ROE is +0.06%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, AFAM is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check ARDT's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AGL trades at $94.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AGL's P/E ratio is -6.09. In terms of profitability, AFAM's ROE is +0.06%, compared to AGL's ROE of -1.19%. Regarding short-term risk, AFAM is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check AGL's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while HCSG trades at $21.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas HCSG's P/E ratio is 17.62. In terms of profitability, AFAM's ROE is +0.06%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, AFAM is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check HCSG's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, INNV has a market cap of 1.5B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while INNV trades at $10.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas INNV's P/E ratio is -122.56. In terms of profitability, AFAM's ROE is +0.06%, compared to INNV's ROE of -0.01%. Regarding short-term risk, AFAM is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check INNV's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while PNTG trades at $39.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas PNTG's P/E ratio is 30.00. In terms of profitability, AFAM's ROE is +0.06%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, AFAM is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check PNTG's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, NUTX has a market cap of 1.4B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while NUTX trades at $196.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas NUTX's P/E ratio is 7.82. In terms of profitability, AFAM's ROE is +0.06%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, AFAM is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check NUTX's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AMN trades at $33.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AMN's P/E ratio is 11.41. In terms of profitability, AFAM's ROE is +0.06%, compared to AMN's ROE of +0.15%. Regarding short-term risk, AFAM is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check AMN's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while BKDT trades at $77.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas BKDT's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, AFAM is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check BKDT's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while USPH trades at $77.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas USPH's P/E ratio is 30.60. In terms of profitability, AFAM's ROE is +0.06%, compared to USPH's ROE of -0.01%. Regarding short-term risk, AFAM is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check USPH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while TALK trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas TALK's P/E ratio is 774.34. In terms of profitability, AFAM's ROE is +0.06%, compared to TALK's ROE of +0.00%. Regarding short-term risk, AFAM is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check TALK's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, GMRS has a market cap of 707.8M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while GMRS trades at $12.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas GMRS's P/E ratio is 5.82. In terms of profitability, AFAM's ROE is +0.06%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, AFAM is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check GMRS's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while EHAB trades at $13.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas EHAB's P/E ratio is -197.14. In terms of profitability, AFAM's ROE is +0.06%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, AFAM is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check EHAB's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, STLN has a market cap of 628.9M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while STLN trades at $6.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas STLN's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to STLN's ROE of +2.10%. Regarding short-term risk, AFAM is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check STLN's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while TOI trades at $5.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas TOI's P/E ratio is -14.25. In terms of profitability, AFAM's ROE is +0.06%, compared to TOI's ROE of +2.10%. Regarding short-term risk, AFAM is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check TOI's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, SRTA has a market cap of 451.7M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while SRTA trades at $5.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas SRTA's P/E ratio is -24.61. In terms of profitability, AFAM's ROE is +0.06%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, AFAM is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check SRTA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while MCTA trades at $29.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas MCTA's P/E ratio is 419.36. In terms of profitability, AFAM's ROE is +0.06%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, AFAM is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check MCTA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, CYH has a market cap of 414.6M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while CYH trades at $2.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas CYH's P/E ratio is 4.03. In terms of profitability, AFAM's ROE is +0.06%, compared to CYH's ROE of +0.21%. Regarding short-term risk, AFAM is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check CYH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AUNA has a market cap of 384.2M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AUNA trades at $5.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AUNA's P/E ratio is 4.68. In terms of profitability, AFAM's ROE is +0.06%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, AFAM is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check AUNA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, VMD has a market cap of 333.7M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while VMD trades at $8.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas VMD's P/E ratio is 24.33. In terms of profitability, AFAM's ROE is +0.06%, compared to VMD's ROE of +0.10%. Regarding short-term risk, AFAM is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check VMD's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while CSU trades at $33.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas CSU's P/E ratio is 0.67. In terms of profitability, AFAM's ROE is +0.06%, compared to CSU's ROE of -0.33%. Regarding short-term risk, AFAM is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check CSU's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AIRS has a market cap of 184.1M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AIRS trades at $2.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AIRS's P/E ratio is -87.00. In terms of profitability, AFAM's ROE is +0.06%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, AFAM is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check AIRS's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, JYNT has a market cap of 115.3M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while JYNT trades at $8.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas JYNT's P/E ratio is 80.90. In terms of profitability, AFAM's ROE is +0.06%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, AFAM is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check JYNT's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while FVE trades at $2.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas FVE's P/E ratio is -5.64. In terms of profitability, AFAM's ROE is +0.06%, compared to FVE's ROE of -0.15%. Regarding short-term risk, AFAM is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check FVE's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while KDLYW trades at $18.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas KDLYW's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, AFAM is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check KDLYW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, PARK has a market cap of 94.7M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while PARK trades at $20.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas PARK's P/E ratio is 28.35. In terms of profitability, AFAM's ROE is +0.06%, compared to PARK's ROE of -0.18%. Regarding short-term risk, AFAM is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check PARK's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, BTMD has a market cap of 64M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while BTMD trades at $1.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas BTMD's P/E ratio is 13.18. In terms of profitability, AFAM's ROE is +0.06%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, AFAM is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check BTMD's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while ALR trades at $1.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas ALR's P/E ratio is -1.11. In terms of profitability, AFAM's ROE is +0.06%, compared to ALR's ROE of -0.15%. Regarding short-term risk, AFAM is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check ALR's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, DCGO has a market cap of 36.5M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while DCGO trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas DCGO's P/E ratio is -0.20. In terms of profitability, AFAM's ROE is +0.06%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, AFAM is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check DCGO's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, CCEL has a market cap of 33.1M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while CCEL trades at $4.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas CCEL's P/E ratio is -13.70. In terms of profitability, AFAM's ROE is +0.06%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, AFAM is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check CCEL's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while IMAC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas IMAC's P/E ratio is -2.27. In terms of profitability, AFAM's ROE is +0.06%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, AFAM is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check IMAC's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, PIII has a market cap of 28.2M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while PIII trades at $8.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas PIII's P/E ratio is -0.26. In terms of profitability, AFAM's ROE is +0.06%, compared to PIII's ROE of +1.61%. Regarding short-term risk, AFAM is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check PIII's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, EUDA has a market cap of 24.5M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while EUDA trades at $12.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -24.74. In terms of profitability, AFAM's ROE is +0.06%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, AFAM is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check EUDA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while CANO-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, AFAM is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check CANO-WT's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AIH trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AIH's P/E ratio is -2.78. In terms of profitability, AFAM's ROE is +0.06%, compared to AIH's ROE of +1.16%. Regarding short-term risk, AFAM is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check AIH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, PIIIW has a market cap of 14.9M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while PIIIW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas PIIIW's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, AFAM is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check PIIIW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while CANO trades at $2.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas CANO's P/E ratio is -0.01. In terms of profitability, AFAM's ROE is +0.06%, compared to CANO's ROE of -1.49%. Regarding short-term risk, AFAM is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check CANO's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while FPCG trades at $1,025.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas FPCG's P/E ratio is 0.09. In terms of profitability, AFAM's ROE is +0.06%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, AFAM is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check FPCG's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AMS trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AMS's P/E ratio is -5.90. In terms of profitability, AFAM's ROE is +0.06%, compared to AMS's ROE of -0.07%. Regarding short-term risk, AFAM is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check AMS's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while FTRP trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas FTRP's P/E ratio is -1.22. In terms of profitability, AFAM's ROE is +0.06%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, AFAM is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check FTRP's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, BMGL has a market cap of 7.3M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while BMGL trades at $4.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas BMGL's P/E ratio is -0.88. In terms of profitability, AFAM's ROE is +0.06%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, AFAM is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check BMGL's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, AIDX has a market cap of 6.9M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while AIDX trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas AIDX's P/E ratio is -1.06. In terms of profitability, AFAM's ROE is +0.06%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, AFAM is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check AIDX's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while MODV trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas MODV's P/E ratio is -0.03. In terms of profitability, AFAM's ROE is +0.06%, compared to MODV's ROE of +1.36%. Regarding short-term risk, AFAM is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check MODV's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while GBNH trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas GBNH's P/E ratio is -0.06. In terms of profitability, AFAM's ROE is +0.06%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, AFAM is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check GBNH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while RHE trades at $2.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas RHE's P/E ratio is -1.79. In terms of profitability, AFAM's ROE is +0.06%, compared to RHE's ROE of -1.31%. Regarding short-term risk, AFAM is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check RHE's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while RHE-PA trades at $0.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, AFAM's ROE is +0.06%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, AFAM is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check RHE-PA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while TOIIW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, AFAM's ROE is +0.06%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, AFAM is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check TOIIW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, STLNW has a market cap of 4M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while STLNW trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas STLNW's P/E ratio is -0.13. In terms of profitability, AFAM's ROE is +0.06%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, AFAM is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check STLNW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while IMACW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas IMACW's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, AFAM is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check IMACW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, EDVA has a market cap of 1.6M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while EDVA trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas EDVA's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to EDVA's ROE of N/A. Regarding short-term risk, AFAM is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check EDVA's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while EUDAW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, AFAM's ROE is +0.06%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, AFAM is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check EUDAW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, CCM has a market cap of 605.8K. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while CCM trades at $3.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas CCM's P/E ratio is -0.28. In terms of profitability, AFAM's ROE is +0.06%, compared to CCM's ROE of +0.06%. Regarding short-term risk, AFAM is more volatile compared to CCM. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check CCM's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, NIVF has a market cap of 72K. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while NIVF trades at $1.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas NIVF's P/E ratio is 0.56. In terms of profitability, AFAM's ROE is +0.06%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, AFAM is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check NIVF's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, NIVFW has a market cap of 43.2K. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while NIVFW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, AFAM's ROE is +0.06%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, AFAM is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check NIVFW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, MNDR has a market cap of 36.9K. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while MNDR trades at $1.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas MNDR's P/E ratio is -0.04. In terms of profitability, AFAM's ROE is +0.06%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, AFAM is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check MNDR's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while TALKW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas TALKW's P/E ratio is 0.00. In terms of profitability, AFAM's ROE is +0.06%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, AFAM is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check TALKW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while DCGOW trades at $1.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas DCGOW's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, AFAM is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check DCGOW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, NFH has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while NFH trades at $11.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas NFH's P/E ratio is -19.75. In terms of profitability, AFAM's ROE is +0.06%, compared to NFH's ROE of -0.06%. Regarding short-term risk, AFAM is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check NFH's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, TVTY has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while TVTY trades at $32.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas TVTY's P/E ratio is 19.06. In terms of profitability, AFAM's ROE is +0.06%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, AFAM is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check TVTY's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while ATIP-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, AFAM is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check ATIP-WT's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, HNGR has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while HNGR trades at $18.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas HNGR's P/E ratio is 19.71. In terms of profitability, AFAM's ROE is +0.06%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, AFAM is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check HNGR's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while SLHGP trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, AFAM's ROE is +0.06%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, AFAM is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check SLHGP's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, DVCR has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while DVCR trades at $10.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas DVCR's P/E ratio is 28.34. In terms of profitability, AFAM's ROE is +0.06%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, AFAM is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check DVCR's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while TLMDW trades at $0.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas TLMDW's P/E ratio is N/A. In terms of profitability, AFAM's ROE is +0.06%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, AFAM is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check TLMDW's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, TLMD has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while TLMD trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas TLMD's P/E ratio is -1.60. In terms of profitability, AFAM's ROE is +0.06%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, AFAM is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check TLMD's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, KND has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while KND trades at $9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas KND's P/E ratio is -1.14. In terms of profitability, AFAM's ROE is +0.06%, compared to KND's ROE of -0.53%. Regarding short-term risk, AFAM is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for AFAM.Check KND's competition here

Almost Family Inc. (NASDAQ: AFAM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AFAM stands at 0. In comparison, SLHG has a market cap of 0. Regarding current trading prices, AFAM is priced at $56.00 on the NASDAQ, while SLHG trades at $0.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AFAM currently has a P/E ratio of N/A, whereas SLHG's P/E ratio is -1.48. In terms of profitability, AFAM's ROE is +0.06%, compared to SLHG's ROE of N/A. Regarding short-term risk, AFAM is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for AFAM.Check SLHG's competition here